Community Health Systems Announces That Lynn Simon, MD, President, Healthcare Innovation and Chief Medical Officer, Will Retire and Transition Into a Consulting Role at the End of the Year
Community Health Systems (NYSE: CYH) announced that Lynn Simon, MD, President of Healthcare Innovation and Chief Medical Officer, will retire from her executive role at the end of the year and transition to a consulting position effective January 1, 2025. Simon, who joined CHS in 2010, has been instrumental in establishing patient safety initiatives, developing transfer and patient access centers, and implementing innovative healthcare technologies.
As part of the succession plan, Miguel Benet, MD, currently Executive Vice President of Clinical Operations, will become the company's President of Clinical Operations and Chief Medical Officer in 2025. The transition aims to ensure continuity in clinical leadership and innovation at CHS.
Community Health Systems (NYSE: CYH) ha annunciato che Lynn Simon, MD, Presidente dell'Innovazione Sanitaria e Direttore Medico, si ritirerà dal suo ruolo dirigenziale alla fine dell'anno e passerà a una posizione di consulenza a partire dal 1 gennaio 2025. Simon, che è entrata a far parte di CHS nel 2010, è stata fondamentale nell'istituzione di iniziative per la sicurezza dei pazienti, nello sviluppo di centri per il trasferimento e l'accesso dei pazienti, e nell'implementazione di tecnologie sanitarie innovative.
Come parte del piano di successione, Miguel Benet, MD, attualmente Vicepresidente Esecutivo delle Operazioni Cliniche, diventerà il Presidente delle Operazioni Cliniche e Direttore Medico dell'azienda nel 2025. La transizione mira a garantire continuità nella leadership clinica e nell'innovazione presso CHS.
Community Health Systems (NYSE: CYH) anunció que Lynn Simon, MD, Presidenta de Innovación en Salud y Directora Médica, se retirará de su cargo ejecutivo a finales de año y pasará a una posición de consultoría a partir del 1 de enero de 2025. Simon, quien se unió a CHS en 2010, ha sido fundamental en el establecimiento de iniciativas de seguridad del paciente, el desarrollo de centros de transferencia y acceso para pacientes, y la implementación de tecnologías innovadoras en salud.
Como parte del plan de sucesión, Miguel Benet, MD, actualmente Vicepresidente Ejecutivo de Operaciones Clínicas, se convertirá en el Presidente de Operaciones Clínicas y Director Médico de la empresa en 2025. La transición tiene como objetivo garantizar la continuidad en el liderazgo clínico y la innovación en CHS.
커뮤니티 헬스 시스템(뉴욕증권거래소: CYH)은 린 시몬, MD가 의료 혁신의 회장이자 최고 의료 책임자로서 그녀의 경영 역할에서 은퇴할 것이라고 발표했습니다. 그녀는 2025년 1월 1일부터 컨설팅 직책으로 전환하게 됩니다. 2010년 CHS에 합류한 시몬은 환자 안전 이니셔티브를 확립하고, 환자 전송 및 접근 센터를 개발하고, 혁신적인 의료 기술을 구현하는 데 중요한 역할을 했습니다.
후계자 계획의 일환으로, 미구엘 베넷, MD는 현재 임상 운영의 이사 부사장으로서 2025년에 임상 운영의 회장 겸 최고 의료 책임자가 될 것입니다. 이 전환은 CHS에서 임상 리더십과 혁신의 연속성을 보장하는 것을 목표로 하고 있습니다.
Community Health Systems (NYSE: CYH) a annoncé que Lynn Simon, MD, Présidente de l'Innovation en Santé et Médecin Cheffe, se retirera de son rôle exécutif à la fin de l'année et passera à un poste de consultant à partir du 1er janvier 2025. Simon, qui a rejoint CHS en 2010, a joué un rôle essentiel dans l'établissement d'initiatives de sécurité des patients, le développement de centres de transfert et d'accès pour les patients, et la mise en œuvre de technologies de santé innovantes.
Dans le cadre du plan de succession, Miguel Benet, MD, actuellement Vice-Président Exécutif des Opérations Cliniques, deviendra le Président des Opérations Cliniques et Médecin Chef de l'entreprise en 2025. Cette transition vise à garantir la continuité du leadership clinique et de l'innovation chez CHS.
Community Health Systems (NYSE: CYH) gab bekannt, dass Lynn Simon, MD, Präsidentin für Gesundheitsinnovation und Chief Medical Officer, zum Ende des Jahres aus ihrer Führungsposition ausscheiden wird und ab dem 1. Januar 2025 in eine Beratungstätigkeit wechseln wird. Simon, die 2010 zu CHS kam, war maßgeblich an der Einrichtung von Patientensicherheitsinitiativen, der Entwicklung von Übertragungs- und Patientenversorgungseinrichtungen sowie der Implementierung innovativer Gesundheitstechnologien beteiligt.
Im Rahmen des Nachfolgeplans wird Miguel Benet, MD, derzeit Executive Vice President für klinische Abläufe, 2025 zum Präsidenten der klinischen Abläufe und Chief Medical Officer des Unternehmens ernannt. Der Übergang zielt darauf ab, die Kontinuität in der klinischen Führung und Innovation bei CHS zu gewährleisten.
- Smooth leadership transition with a long-term succession plan in place
- Retention of Lynn Simon's expertise through a consulting arrangement
- Implementation of innovative technologies improving care delivery and patient experience
- Significant reduction (90%) in serious safety event rate over the past decade
- Development of proprietary Transfer Center and Patient Access Center driving growth
- None.
Simon joined Community Health Systems (CHS) in 2010 and has served as Chief Medical Officer since 2017. During her 14-year career at CHS, Simon’s broad areas of responsibility have included every aspect of clinical operations.
Among her many accomplishments at CHS, Simon established one of the first AHRQ-certified Patient Safety Organizations (PSO) along with the framework, expectations, and tools that helped achieve a
In early 2023, Simon assumed a new executive leadership role designed to accelerate innovation across CHS. Simon has forged relationships and implemented technologies that are improving care delivery, creating better patient experiences, streamlining workflows, and improving the work experience for clinicians and support teams. Some of these advancements include implementation of a remote patient monitoring program for people with chronic conditions that currently serves more than 14,000 people, a virtual patient sitting program that is designed to provide 24/7 monitoring to help protect hospitalized patients at high risk for falls, a maternal-fetal early warning system that uses AI to improve safety in childbirth, and a partnership with Mark Cuban Cost Plus Drugs that is addressing drug shortages and the rising costs of pharmaceuticals used in hospital settings.
Commenting on today’s announcement Tim L. Hingtgen, Chief Executive Officer of Community Health Systems, Inc., said, “Lynn’s numerous contributions across the CHS organization and over many years have positively affected patient care and clinical outcomes, improved the experience of our clinicians, advanced our culture in meaningful ways, and will have long-lasting and significant impact. I am so grateful for her leadership and look forward to working with her more in the years ahead.”
As part of a long-term succession plan, Miguel Benet, MD, Executive Vice President of Clinical Operations, will become the Company’s President of Clinical Operations and Chief Medical Officer beginning in 2025. Dr. Benet currently oversees all of the Company’s clinical services and operations, including emergency medicine, surgical services, cardiovascular care, obstetrics and other service lines, clinical research, nursing, pharmacy services, data science and AI, clinical process improvements, care management, clinical documentation and utilization review, physician coding and documentation, Graduate Medical Education programs, and a broad range of initiatives to advance safety, quality and clinical outcomes.
Hingtgen said, “Miguel is an extremely accomplished clinical and operational leader who is highly regarded by physicians, nurses, health system administrators, and his colleagues at CHS. He is a solutions-oriented leader whose unique perspectives already are advancing clinical care in our health systems. CHS will continue to benefit from Miguel’s expertise and commitment to the future of medicine as he assumes the role of President of Clinical Operations and Chief Medical Officer next year.”
In addition to her consulting role at CHS, Simon plans to remain involved in the healthcare industry with a continuing focus on innovation. Simon has cultivated relationships with venture capital firms, start-up companies, and others who are creating new solutions for healthcare. In addition, she looks forward to focusing on current and potential future board and advisory opportunities. Simon serves on the board of directors for Ascend Learning, ForeFront Dermatology, and Cadence. Simon has received numerous awards and recognitions, including being named to Modern Healthcare’s lists of the Top Healthcare Innovators, 50 Most Influential Physician Executives and Leaders, and the Top 25 Women in Healthcare.
About Community Health Systems, Inc.
Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company’s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 39 distinct markets across 15 states. The Company’s subsidiaries own or lease 70 affiliated hospitals with more than 11,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” The Company’s headquarters are located in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911869685/en/
Media Contact:
Tomi Galin
Executive Vice President – Corporate Communications and Marketing
615-628-6607
Investor Contacts:
Kevin J. Hammons
President and Chief Financial Officer
615-465-7000
or
Anton Hie
Vice President – Investor Relations
615-465-7012
Source: Community Health Systems, Inc.
FAQ
When will Lynn Simon, MD retire from her executive role at Community Health Systems (CYH)?
Who will replace Lynn Simon as Chief Medical Officer at Community Health Systems (CYH)?
What are some key achievements of Lynn Simon during her tenure at Community Health Systems (CYH)?
How long has Lynn Simon been with Community Health Systems (CYH)?
